—
Market InsightsThe steady increase in the market for neurostimulation treatment is majorly driven by growing increasing incidence of neurological disorders worldwide, a significant gap in the outcomes of existing treatments, and growing demand for gaining quality of life, containing treatment costs and side-effects. Neurosurgeons are increasingly seeking further efficient surgical modalities that offer lesser treatment complexities and are minimally invasive in nature and have longer efficacy than the conventional treatments. This report studies the global neurostimulation devices market based on device types, therapeutic areas and geographic distribution.
Browse the full report Neurostimulation Devices Market Growth, Future Prospects and Competitive Analysis, 2016-2024 at https://www.credenceresearch.com/report/neurostimulation-devices-market
Among the many device types, spinal cord stimulators currently offer the most significant market potential and the growth of this segment is driven by its growing applications in treating chronic pain. In addition, sacral nerve stimulators is supposed to be the fastest progressing segment throughout the projection period due to the increasing prevalence of incontinence patient base worldwide. Deep brain stimulators are used in the treatment of degenerative disorders such as Alzheimer’s and Parkinson’s disease. These stimulators are currently based on bourgeoning technologies and further innovation in the nature of these systems and their treatment outcomes will offer promising growth opportunities to this segment. Their anticipated extension in treating conditions such as refractory epilepsy, Tourette syndrome, cluster headache, movement dysfunctions and trigeminal neuralgia will fuel market growth.
Pain management is the mainstay of neurostimulation applications, highest prevalence of chronic pain, surgical pain and trauma related pain are the major therapeutic areas where neurostimulation devices are extensively used as adjunct to conventional medication administration. In addition, the market size of neurostimulation devices for treating Parkinson’s disease is expected to progress a an impressive growth rate due to large geriatric patient pool and proven efficiency of neurostimulation devices in treating neurological disorders. Other conditions such as migraine and epilepsy are observed to have high unmet needs in terms of efficient treatment. Such gaps between the disease prevalence and treatment efficiency essentially serve a lucrative market opportunities for neurostimulation devices market.
Pain management constitutes the largest therapeutic area where neurostimulation devices find the widest application. High global prevalence of pain disorders, such as chronic pain, surgical pain and others that interfere with the quality of life and growing adoption of neurostimulation devices on the ground of their better therapeutic value are some of the key drivers of this segment. Other therapeutic areas such as neurostimulation devices market for Parkinson’s disease, epilepsy, gastric conditions are also anticipated to undergo impressive growth rate during the forecast period on the ground of improved treatment efficiency, rising disease prevalence in the senescent population base and continuous product innovations.
Geographically, North America and Western Europe together capture the largest market in 2015 and North America is expected to maintain its lead during the projection period. The existence of evolved healthcare system, higher patient base and availability of favorable reimbursement policies will remain the chief growth drivers in North America market. On the other hand, Asia Pacific and Latin America are expected to be the fastest progressing regional markets during the forecast period. Prevalence of huge geriatric population in countries such as Japan, India, China, Mexico and others who bear a high risk and incidence of neurological and neurodegenerative diseases and perpetual evolution of healthcare infrastructure in the regions, along with rising awareness about management of these diseases are the key growth drivers in Latin America and Asia Pacific markets.
(Device Type: Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator & Gastric Electric Stimulators; Therapeutic Areas: Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression Dystonia, Gastroparesis, Parkinson's Disease & Others)
ToC:
Chapter 5 Global Neurostimulation Devices Market (US$ Mn), By Therapeutic Areas, 2013-2024
5.1 Introduction
5.2 Pain Management
5.3 Epilepsy
5.4 Essential Tremors
5.5 Urinary and Fecal Incontinence
5.6 Depression
5.7 Dystonia
5.8 Gastroparesis
5.9 Parkinson’s Disease
5.10 Others
Chapter 6 Global Neurostimulation Devices Market (US$ Mn), By Geography, 2013-2024
6.1 Preface
6.2 North America (U.S., Canada)
6.3 Europe (U.K., Germany, Rest of Europe)
6.4 Asia Pacific (Japan, China, Rest of Asia Pacific)
6.5 Latin America (Brazil, Mexico, Rest of LATAM)
6.6 Middle East and Africa (Saudi Arabia, South Africa, Rest of MEA)
Chapter 7 Company Profiles
7.1 Medtronic
7.2 St. Jude Medical
7.3 Boston Scientific Corporation
7.4 Cyberonics
7.5 Nevro Corp
7.6 Cogentix Medical
7.7 Neuronetics, Inc.
7.8 IntraPace, Inc.
7.9 Codman & Shurtleff, Inc.
7.10 Other Notable Players
...........................toc continued
Browse the full report Neurostimulation Devices Market Growth, Future Prospects and Competitive Analysis, 2016-2024 at https://www.credenceresearch.com/report/neurostimulation-devices-market
List Of Table :
TABLE 1 Global Neurostimulation Devices Market (US$ Mn), By Type, 2013-2024
TABLE 2 Global Neurostimulation Devices Market (US$ Mn), By Therapeutic Areas, 2013-2024
TABLE 3 Global Neurostimulation Devices Market (US$ Mn), by Geography, 2013–2024
TABLE 4 North America Neurostimulation Devices Market (US$ Mn), by Country, 2013–2024
TABLE 5 North America Neurostimulation Devices Market (US$ Mn), by Type, 2013–2024
TABLE 6 North America Neurostimulation Devices Market (US$ Mn), by Therapeutic Area, 2013–2024
TABLE 7 Europe Neurostimulation Devices Market, by Country, 2013–2024 (US$ Mn)
TABLE 8 Europe Neurostimulation Devices Market (US$ Mn), by Type, 2013–2024
TABLE 9 Europe Neurostimulation Devices Market (US$ Mn), by Therapeutic Area, 2013–2024
TABLE 10 Europe Neurostimulation Devices Market (US$ Mn), by Country, 2013–2024
TABLE 11 Asia Pacific Neurostimulation Devices Market (US$ Mn), by Type, 2013–2024
..........................continued
Browse the full report Neurostimulation Devices Market Growth, Future Prospects and Competitive Analysis, 2016-2024 at https://www.credenceresearch.com/report/neurostimulation-devices-market
Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com
Release ID: 480965
Google
RSS